Nisha Mohindra

4.5k total citations
66 papers, 1.4k citations indexed

About

Nisha Mohindra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nisha Mohindra has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Nisha Mohindra's work include Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cancer Genomics and Diagnostics (15 papers). Nisha Mohindra is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cancer Genomics and Diagnostics (15 papers). Nisha Mohindra collaborates with scholars based in United States, Philippines and Australia. Nisha Mohindra's co-authors include Young Kwang Chae, Francis J. Giles, Victoria Villaflor, Maria Matsangou, Alan Pan, Aparna Kalyan, Benedito A. Carneiro, Massimo Cristofanilli, Kirtee Raparia and Andrew A. Davis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nisha Mohindra

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nisha Mohindra United States 16 741 450 364 306 217 66 1.4k
Tatsuhiro Shibata Japan 15 551 0.7× 266 0.6× 522 1.4× 282 0.9× 136 0.6× 41 1.4k
Miguel Gil‐Gil Spain 23 814 1.1× 619 1.4× 322 0.9× 396 1.3× 139 0.6× 101 1.7k
Dorothee Gramatzki Switzerland 19 335 0.5× 345 0.8× 444 1.2× 343 1.1× 154 0.7× 59 1.4k
Rakesh Gaur United States 17 901 1.2× 336 0.7× 277 0.8× 432 1.4× 94 0.4× 39 1.6k
R. Rampling United Kingdom 19 500 0.7× 681 1.5× 565 1.6× 452 1.5× 205 0.9× 30 2.1k
J. Biau France 20 440 0.6× 471 1.0× 340 0.9× 147 0.5× 134 0.6× 113 1.3k
Huihua Li Singapore 20 409 0.6× 184 0.4× 285 0.8× 189 0.6× 106 0.5× 50 1.2k
Hua Bai China 17 858 1.2× 422 0.9× 200 0.5× 172 0.6× 82 0.4× 43 1.3k
Vito Amoroso Italy 18 711 1.0× 340 0.8× 151 0.4× 255 0.8× 194 0.9× 71 1.1k
Monika Hackl Austria 18 1.0k 1.4× 636 1.4× 325 0.9× 132 0.4× 464 2.1× 40 1.7k

Countries citing papers authored by Nisha Mohindra

Since Specialization
Citations

This map shows the geographic impact of Nisha Mohindra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nisha Mohindra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nisha Mohindra more than expected).

Fields of papers citing papers by Nisha Mohindra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nisha Mohindra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nisha Mohindra. The network helps show where Nisha Mohindra may publish in the future.

Co-authorship network of co-authors of Nisha Mohindra

This figure shows the co-authorship network connecting the top 25 collaborators of Nisha Mohindra. A scholar is included among the top collaborators of Nisha Mohindra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nisha Mohindra. Nisha Mohindra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohindra, Nisha, Sofia F. Garcia, Sheetal Kircher, et al.. (2024). Development of an electronic health record-integrated patient-reported outcome-based shared decision-making dashboard in oncology. JAMIA Open. 7(3). ooae056–ooae056. 5 indexed citations
2.
O’Connor, Mary, John Devin Peipert, Sofia F. Garcia, et al.. (2024). Implementation of a Co-Design Strategy to Develop a Dashboard to Support Shared Decision Making in Advanced Cancer and Chronic Kidney Disease. Journal of Clinical Medicine. 13(14). 4178–4178. 1 indexed citations
3.
Mohindra, Nisha, John Devin Peipert, Steven I. Blum, et al.. (2023). General population reference values for the Functional Assessment of Cancer Therapy‐Lung and PROMIS‐29. Cancer Medicine. 12(11). 12765–12776. 7 indexed citations
4.
Gentzler, Ryan D., Nisha Mohindra, Shadia I. Jalal, et al.. (2023). Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175. The Oncologist. 29(1). 47–56. 3 indexed citations
5.
Le, Xiuning, Elaine Shum, Christina S. Baik, et al.. (2023). LBA71 A multi-centre open-label randomized phase II study of osimertinib with and without ramucirumab in TKI-naïve EGFR-mutant metastatic NSCLC (RAMOSE trial interim analysis). Annals of Oncology. 34. S1313–S1314. 8 indexed citations
6.
Oh, Michael S., Derek A. Wainwright, Nisha Mohindra, et al.. (2020). The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Clinical Lung Cancer. 22(1). e57–e62. 57 indexed citations
7.
Hassanzadeh, Comron, Timothy L. Sita, Pamela Samson, et al.. (2020). Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer. Journal of Thoracic Disease. 12(11). 6690–6700. 23 indexed citations
8.
Davis, Andrew A., Jonghanne Park, Wade T. Iams, et al.. (2020). Abstract 5527: Serum proteomic scores for understanding the mechanisms of immune-related adverse events (irAEs) in non-small cell lung cancer. Cancer Research. 80(16_Supplement). 5527–5527. 1 indexed citations
9.
Simon, Nicholas I., Young Kwang Chae, Nisha Mohindra, & Victoria Villaflor. (2019). P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment. Journal of Thoracic Oncology. 14(10). S623–S624. 1 indexed citations
10.
Davis, Andrew A., Wade T. Iams, David Chan, et al.. (2019). P1.01-49 Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC. Journal of Thoracic Oncology. 14(10). S377–S377. 1 indexed citations
11.
Sita, Timothy L., Comron Hassanzadeh, Pamela Samson, et al.. (2019). OA03.03 Multi-Institutional Study of Pneumonitis After Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1131–S1132. 2 indexed citations
12.
13.
14.
Chae, Young Kwang, Ayush Arya, Wade T. Iams, et al.. (2018). Immune checkpoint pathways in non-small cell lung cancer. Annals of Translational Medicine. 6(5). 88–88. 13 indexed citations
15.
Mohindra, Nisha, et al.. (2018). Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer. JAAD Case Reports. 4(10). 1042–1044. 18 indexed citations
16.
Chae, Young Kwang, Alan Pan, Andrew A. Davis, et al.. (2016). Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?. Clinical Lung Cancer. 17(5). 350–361. 91 indexed citations
17.
Chae, Young Kwang, Alan Pan, Andrew A. Davis, et al.. (2016). Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer. Clinical Lung Cancer. 18(2). 132–140. 14 indexed citations
18.
Chae, Young Kwang, et al.. (2016). A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes. Cancer Immunology Immunotherapy. 66(1). 25–32. 92 indexed citations
19.
Mohindra, Nisha & Mark Agulnik. (2015). Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas. Expert Opinion on Investigational Drugs. 24(11). 1409–1418. 6 indexed citations
20.
Mohindra, Nisha, et al.. (2009). Eating patterns and overweight status in young adults: the Bogalusa Heart Study. International Journal of Food Sciences and Nutrition. 60(sup3). 14–25. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuhiro Shibata Breakdown of academic impact, for papers by Miguel Gil‐Gil Breakdown of academic impact, for papers by Dorothee Gramatzki Breakdown of academic impact, for papers by Rakesh Gaur Breakdown of academic impact, for papers by R. Rampling Breakdown of academic impact, for papers by J. Biau Breakdown of academic impact, for papers by Huihua Li Breakdown of academic impact, for papers by Hua Bai Breakdown of academic impact, for papers by Vito Amoroso Breakdown of academic impact, for papers by Monika Hackl
Rankless by CCL
2026